Universal-Beteiligungs- und Servicegesellschaft
ARQT icon

Universal-Beteiligungs- und Servicegesellschaft’s Arcutis Biotherapeutics ARQT Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$823K Sell
31,392
-158,622
-83% -$3.7M ﹤0.01% 1635
2026
Q1 		$4.48M Sell
190,014
-44,057
-19% -$1.12M 0.01% 922
2025
Q4 		$6.8M Buy
234,071
+147,586
+171% +$3.78M 0.01% 755
2025
Q3 		$1.63M Buy
+86,485
New +$1.36M ﹤0.01% 1374

Other funds holding ARQT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ARQT Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Arcutis Biotherapeutics (ARQT) stake by 83% in Q2 2026, selling an estimated $3.7M and leaving 31,392 shares worth $823K. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ARQT in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.8M in Q4 2025. 139 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 31,392 shares of Arcutis Biotherapeutics worth $823K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 158,622 Arcutis Biotherapeutics shares in Q2 2026, an estimated $3.7M.
  • Arcutis Biotherapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1635 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Arcutis Biotherapeutics in Q3 2025 and has held it in 4 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Arcutis Biotherapeutics position peaked at $6.8M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.